Clene Inc. Common Stock

CLNNNASDAQ • USD
3.88 USD
↗ 0.00 (0.00%)AT CLOSE (03:59 PM EDT)
3.94
↗ 0.06 (1.42%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
3.94
↗ 0.06 (1.42%)
🔴Market: CLOSED

Shares of Clene Inc. Common Stock (CLNN) are trading at $3.88. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (159.5%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Oct 23, 2026.

Open?$3.79
High?$3.97
Low?$3.77
Prev. Close?$3.88
Volume?21.4K
Avg. Volume?123.4K
VWAP?$3.87
Rel. Volume?0.17x
Bid / Ask
Bid?$3.33 × 100
Ask?$4.51 × 100
Spread?$1.18
Midpoint?$3.92
Valuation & Ratios
Market Cap?55.2M
Shares Out?N/A
Float?9.3M
Float %?71.3%
P/E Ratio?N/A
P/B Ratio?-2.23
EPS?-$2.78
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Employees
79
Market Cap
55.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-12-31
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
54
Piotroski F-Score?2/9Weak
Altman Z-Score?-21.76Distress
Confidence?56%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.51%Elevated
Short Interest?880.7K
Days to Cover?7.5
Free Float9.3M
Avg Daily Volume117.4K
Settlement Date2026-09-30
Financial Health
Current Ratio?3.07Strong
Quick Ratio?3.07Strong
Cash Ratio?1.99Strong
Debt/Equity?-0.76Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-2.23CHEAP▾
P/S?
Peers
100
S&P
3
279.95HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
325.90HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
159.5%STRONG▾
ROA?
S&P
3
-171.5%WEAK▾
Cash Flow & Enterprise
FCF?$-15947000
Enterprise Value?$64.2M
Fundamentals ratios updated end of day